[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-245304-105":53,"doc-detail-245304-en":118},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":111,"head_meta":113,"extra_data":115,"updated_unix":117},105,"en","pianoforte-travel-grant-activity-report-michelle-andersson-at-eanm-2023","PIANOFORTE travel grant activity report - Michelle Andersson at EANM 2023","","PIANOFORTE travel grant activity report by Michelle Andersson (SCK CEN) summarizing an oral presentation at the European Association of Nuclear Medicine annual congress (EANM) on 2023-09-10. The report covers the five-day Vienna meeting and highlights the breadth of nuclear medicine topics, from isotope production and dosimetry to clinical trials and radiopharmaceuticals. It describes how presenting preclinical dosimetry in the Cutting edge science session, plus attending clinical-oriented discussions, supported insight and future collaborations, including funding via the EU EURATOM program under grant 101061037.",{"@graph":63,"@context":110},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":16,"@type":70,"position":76},"https://docshare.wps.com/template/resumes/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/pianoforte-travel-grant-activity-report-michelle-andersson-at-eanm-2023/245304/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/pianoforte-travel-grant-activity-report-michelle-andersson-at-eanm-2023/245304.png","ImageObject",442,249,{"name":88,"@type":89},"Eden","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-16","2026-09-12",true,{"@type":98,"interactionType":99,"userInteractionCount":73},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104],{"name":105,"@type":106,"acceptedAnswer":107},"How did attending the congress help her research and collaborations?","Question",{"text":108,"@type":109},"Attending sessions across clinical and preclinical dosimetry supported her understanding of how preclinical work can better inform clinical needs, and her abstract presentation helped enable future collaborations through connections and shared ideas.","Answer","https://schema.org",{"og:url":78,"og:type":112,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":114,"canonical":78},"index,follow",{"doc_id":116,"site_id":56},245304,1792185243,{"code":4,"msg":5,"data":119},{"doc_id":116,"user_id":120,"nickname":88,"user_avatar":121,"doc_module":9,"category_id":15,"category_name":16,"doc_title":59,"doc_description":61,"doc_content":122,"file_id":123,"file_url":124,"file_type":125,"file_size":126,"view_count":73,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":9,"language":127,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":128,"faqs":129,"seo_title":130,"seo_description":61,"update_tm":131,"read_time":4},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","PIANOFORTE travel grant activity report  \nMichelle Andersson, SCK CEN  \nOral presentation at EANM 2023-09-10  \nThe annual congress of the European Association of Nuclear Medicine (EANM) is key for presenting the leading research in Nuclear Medicine each year, covering presentations, ePosters, discussion boards, interactive sessions and social activities including researchers from all over the world, with the number of visitors in 2022 being 7000 participants.  \nThe 2023 EANM congress spanned over 5 days, and was held in Vienna, Austria, sharing the latest developments in nuclear medicine. It covers many broad topics, such as isotope production, preclinical and clinical dosimetry, clinical trials, new and emerging radiopharmaceuticals and future needs and improvements of patient treatments.  \nI was invited to present our abstract in the Cutting edge science session on preclinical Dosimetry on Sunday, September 10th, which was an incredibly positive experience for me as an early career researcher. As my PhD project is focused on preclinical dosimetry, the opportunity to be able to attend other sessions covering clinical dosimetry and improvements on patient treatments was helpful for me to gain better insight on how the preclinical research can better support the needs from clinical centers.  \nThe abstract that I presented was the result of a fruitful collaboration with the University of Paris, and being able to communicate our research and making new connections enables possible future collaborations, leading to further advancement through exchange of ideas and findings, as well as learning through attending sessions on the latest developments in all subjects related to nuclear medicine research. By attending the EANM covering such a broad span of topics, it was possible forme to gain a better understanding on all of the different factors affecting Nuclear Medicine research.  \nPersonally, the opportunity to be able to attend and present in such a setting has been an overwhelmingly positive experience. During the five days of the conference the setting of presentation sessions, posters and discussion sessions enabled me to make new connections, gain insights on the different approaches to such an emerging field, and to understand different viewpoints depending on background and experience. By joining the different types of sessions, I managed to get more insight on the clinical perspectives and considerations, and how to better translate this to a preclinical setting.  \nThis partnership has received funding from the European Union’s “EURATOM” research and innovation program under the 101061037 grant agreement.","cbCaisgSV1gLSq7V","https://ap.wps.com/l/cbCaisgSV1gLSq7V","pdf",356568,"English","# PIANOFORTE travel grant activity report\n## Event overview and scientific focus\n## Presentation invitation and research context\n## Collaboration outcomes and conference impact\n## Funding acknowledgement","[{\"question\":\"How did attending the congress help her research and collaborations?\",\"answer\":\"Attending sessions across clinical and preclinical dosimetry supported her understanding of how preclinical work can better inform clinical needs, and her abstract presentation helped enable future collaborations through connections and shared ideas.\"}]","PIANOFORTE travel grant activity report - Michelle Andersson at EANM 2023 | PDF",1789227314]